Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,507 | 41 | 69.1% |
| Travel and Lodging | $8,117 | 42 | 15.0% |
| Food and Beverage | $6,423 | 243 | 11.8% |
| Consulting Fee | $2,160 | 3 | 4.0% |
| Education | $81.61 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25,209 | 64 | $0 (2023) |
| ABBVIE INC. | $16,524 | 106 | $0 (2023) |
| Janssen Biotech, Inc. | $6,140 | 17 | $0 (2023) |
| Celgene Corporation | $2,701 | 27 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $1,588 | 11 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $743.29 | 38 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $361.03 | 22 | $0 (2023) |
| Ardelyx, Inc. | $275.66 | 10 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $146.92 | 4 | $0 (2023) |
| Gilead Sciences, Inc. | $132.65 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $27,246 | 99 | E.R. Squibb & Sons, L.L.C. ($13,532) |
| 2022 | $13,385 | 130 | ABBVIE INC. ($7,043) |
| 2021 | $13,658 | 102 | E.R. Squibb & Sons, L.L.C. ($7,210) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Gastroenterology | ||||||
| 06/23/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $552.00 | General |
| Category: Neuroscience | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $295.14 | General |
| Category: Neuroscience | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $60.39 | General |
| Category: Neuroscience | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $50.38 | General |
| Category: Neuroscience | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $38.00 | General |
| Category: Neuroscience | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.83 | General |
| Category: Neuroscience | ||||||
| 06/14/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $11.97 | General |
| Category: GI | ||||||
| 06/12/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $75.00 | General |
| Category: Immunology | ||||||
| 06/12/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Immunology | ||||||
| 06/10/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Travel and Lodging | Cash or cash equivalent | $35.03 | General |
| Category: Immunology | ||||||
| 06/08/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/08/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: Immunology | ||||||
| 06/07/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: GI | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Gastroenterology | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,656.00 | General |
| Category: Neuroscience | ||||||
| 05/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Immunology | ||||||
| 05/25/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,656.00 | General |
| Category: Neuroscience | ||||||
| 05/25/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $736.00 | General |
| Category: Neuroscience | ||||||
| 05/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/24/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $122.58 | General |
| Category: Immunology | ||||||
| 05/16/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $150.48 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 301 | 323 | $56,634 | $15,253 |
| 2022 | 5 | 625 | 770 | $134,055 | $41,298 |
| 2021 | 6 | 679 | 797 | $137,789 | $44,980 |
| 2020 | 5 | 586 | 669 | $104,245 | $27,978 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 160 | $30,400 | $8,596 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 135 | $18,352 | $4,406 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $3,696 | $1,222 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,186 | $1,029 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 325 | $61,750 | $19,632 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 274 | 337 | $44,640 | $13,320 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $16,445 | $4,891 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 32 | $8,448 | $2,838 | 33.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 21 | $2,772 | $617.81 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 322 | 410 | $74,959 | $25,256 | 33.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 231 | 258 | $32,526 | $10,643 | 32.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $16,076 | $4,456 | 27.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 42 | $10,419 | $3,679 | 35.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,289 | $546.60 | 23.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 20 | $1,520 | $398.98 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 199 | 225 | $38,925 | $10,441 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 269 | 326 | $38,142 | $10,041 | 26.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 71 | 71 | $18,346 | $4,968 | 27.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 34 | 34 | $7,922 | $2,286 | 28.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $910.00 | $241.90 | 26.6% |
About Lonniel Bain, NP
Lonniel Bain, NP is a Family healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548309495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lonniel Bain, NP has received a total of $54,289 in payments from pharmaceutical and medical device companies, with $27,246 received in 2023. These payments were reported across 331 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,507).
As a Medicare-enrolled provider, Bain has provided services to 2,191 Medicare beneficiaries, totaling 2,559 services with total Medicare billing of $129,508. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Williamsburg, VA
- Active Since 02/06/2007
- Last Updated 09/30/2013
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1548309495
Products in Payments
- ZEPOSIA (Drug) $26,110
- STELARA (Biological) $6,287
- LINZESS (Drug) $5,687
- CREON (Drug) $5,239
- RINVOQ (Biological) $3,360
- SKYRIZI (Biological) $1,874
- Linzess (Drug) $1,588
- TRULANCE (Drug) $590.20
- ENTYVIO (Biological) $314.56
- IBSRELA (Drug) $275.66
- XIFAXAN (Drug) $144.67
- DUPIXENT (Biological) $131.30
- HUMIRA (Biological) $110.13
- ZENPEP (Drug) $102.31
- MAVYRET (Drug) $89.55
- VIBERZI (Drug) $88.03
- DIFICID (Drug) $78.32
- XELJANZ (Drug) $69.41
- INFLECTRA (Biological) $35.05
- MOTEGRITY (Drug) $24.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Williamsburg
Mrs. Shannon Dishman, Fnp, FNP
Family — Payments: $19,859
Mr. Ralph Ablaseau, Np-C, NP-C
Family — Payments: $6,669
Mrs. Christen Proffitt, C-Fnp, C-FNP
Family — Payments: $4,811
Jennifer Fisher, Fnp, FNP
Family — Payments: $4,801
Gloria Kim, Pmhnp-Bc, Fnp-Bc, PMHNP-BC, FNP-BC
Family — Payments: $4,630
Mary Scaggs
Family — Payments: $4,309